# An Observational Study For Ambrisentan

> **NCT00679224** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 800 (actual)

## Conditions studied

- Hypertension, Pulmonary

## Interventions

- **DRUG:** ambrisentan

## Key facts

- **NCT ID:** NCT00679224
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679224, "An Observational Study For Ambrisentan". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00679224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*